Latest News view all news
08/25/2023
FDA-approval in Multiple Myeloma
08/04/2023
New FDA Approval for Taiho Oncology, Inc
Taiho Oncology, Inc., is pleased to inform you that the “FDA Approves LONSURF® (trifluridine/tipiracil) in Combination With Bevacizumab for Adult Patients With Metastatic Colorectal Cancer (mCRC),” has been issued on Aug. 2, 2023.